Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Receives Average Recommendation of “Moderate Buy” from Analysts

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) has been given an average rating of “Moderate Buy” by the six analysts that are currently covering the stock, MarketBeat reports. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $27.3333.

KMTS has been the topic of a number of analyst reports. Wells Fargo & Company reduced their price target on Kestra Medical Technologies from $28.00 to $27.00 and set an “overweight” rating on the stock in a research report on Thursday, July 17th. Wall Street Zen upgraded Kestra Medical Technologies from a “sell” rating to a “hold” rating in a research report on Saturday.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Quarry LP bought a new position in Kestra Medical Technologies in the first quarter worth approximately $33,000. Police & Firemen s Retirement System of New Jersey bought a new position in Kestra Medical Technologies in the second quarter worth approximately $54,000. New York State Common Retirement Fund bought a new position in Kestra Medical Technologies in the second quarter worth approximately $93,000. Virtu Financial LLC bought a new position in Kestra Medical Technologies in the first quarter worth approximately $210,000. Finally, Walleye Capital LLC bought a new position in Kestra Medical Technologies in the second quarter worth approximately $166,000.

Kestra Medical Technologies Stock Performance

Shares of KMTS opened at $24.94 on Monday. Kestra Medical Technologies has a 12-month low of $13.25 and a 12-month high of $27.71. The business has a 50-day simple moving average of $17.33 and a two-hundred day simple moving average of $19.99. The company has a quick ratio of 6.84, a current ratio of 6.84 and a debt-to-equity ratio of 0.23.

About Kestra Medical Technologies

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.